| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |